Memorial Sloan Kettering’s Chief Executive Resigns From Merck’s Board of Directors

This article was reported and written in a collaboration with ProPublica, the nonprofit journalism organization. Dr. Craig B. Thompson, the chief executive of Memorial Sloan Kettering Cancer Center, said Tuesday that he would resign his seats on the boards of drug maker Merck and another public company, the latest fallout from a widening institutional reckoning…

Details